FUND PARTICIPATION AGREEMENT

This Agreement is entered into as of the 11 day of January, 2000, among Conseco
Variable Insurance Company (Insurance Company), a life insurance company
organized under the laws of the State of Texas. LAZARD ASSET MANAGEMENT ("LAM"),
a division of Lazard Freres & Co. LLC, a New York limited liability company,
and LAZARD RETIREMENT SERIES, INC. (the "Fund"), a corporation organized under
the laws of the State of Maryland, with respect to the Fund's portfolios set
forth on Schedule 1 hereto, as such Schedule may be revised from time to time
(each, a "Portfolio").

                                   ARTICLE I.
                                  DEFINITIONS

        1.1.    "Act" shall mean the Investment Company Act of 1940, as amended.

        1.2.    "Board" shall mean the Board of Directors of the Fund having the
        responsibility for management and control of the Fund.

        1.3.    "Business Day" shall mean any day for which the Fund calculates
        net asset value per share as described in the Fund's Prospectus.

        1.4.    "Commission" shall mean the Securities and Exchange Commission.

        1.5.    "Contract" shall mean a variable annuity contract and/or
        variable life contract that uses the Fund as an underlying investment
        medium. Individuals who participate under a group Contract are
        "Participants."

        1.6.    "Contractholder" shall mean any entity that is a party to a
        Contract with a Participating Company.

        1.7.    "Disinterested Board Members" shall mean those members of the
        Board that are not deemed to be "interested persons" of the Fund, as
        defined by the Act.

        1.8.    "Participating Companies" shall mean any insurance company
        (including Insurance Company), which offers variable annuity and/or
        variable life insurance contracts to the public and which has entered
        into an agreement with the Fund for the purpose of making Fund shares
        available to serve as the underlying investment medium for the aforesaid
        Contracts.

        1.9.    "Prospectus" shall mean the Fund's current prospectus and
        statement of additional information, as most recently filed with the
        Commission, with respect to the Portfolios.

        1.10.   "Separate Account" shall mean Conseco Variable Accounts C, E, F,
        G & H and Conseco Variable Life Account A, separate accounts established
        by Insurance Company in accordance with the laws of the State of Texas.

        1.11.   "Software Program" shall mean the software program used by the
        Fund for providing Fund and account balance information including net
        asset value per share.

        1.12.   "Insurance Company's General Account(s)" shall mean the general
        account(s) of Insurance Company and its affiliates which invest in the
        Fund.



                                   ARTICLE II.
                                 REPRESENTATIONS

        2.1.    Insurance Company represents and warrants that (a) it is an
        insurance company duly organized and in good standing under applicable
        law; (b) it has legally and validly established the Separate Account
        pursuant to the Texas Insurance Code for the purpose of offering to the
        public certain individual variable annuity contracts; (c) it has
        registered the Separate Account as a unit investment trust under the Act
        to serve as the segregated investment account for the Contracts; and (d)
        each Separate Account is eligible to invest in shares of the Fund
        without such investment disqualifying the Fund as an investment medium
        for insurance company separate accounts supporting variable annuity
        contracts or variable life insurance contracts.

        2.2.    Insurance Company represents and warrants that (a) the Contracts
        will be described in a registration statement filed under the Securities
        Act of 1933. as amended ("1933 Act"); (b) the Contracts will be issued
        and sold in compliance in all material respects with all applicable
        federal and state laws; and (c) the sale of the Contracts shall comply
        in all material respects with state insurance law requirements.
        Insurance Company agrees to inform the Fund promptly of any investment
        restrictions imposed by state insurance law and applicable to the Fund.

        2.3.    Insurance Company represents and warrants that the Contracts
        currently are and at the time of issuance will be treated as life
        insurance, endowment or annuity contracts under applicable provisions of
        the Internal Revenue Code of 1986, as amended (the "Code"), that it will
        maintain such treatment and that it will notify the Fund immediately
        upon having a reasonable basis for believing that the Contracts have
        ceased to be so treated or that they might not be so treated in the
        future.

        2.4.    Fund represents that the Fund is registered with the Commission
        under the Act as an open-end, management investment company and
        possesses, and shall maintain, all legal and regulatory licenses,
        approvals, consents and/or exemptions required for the Fund to operate
        and offer its shares as an underlying investment medium for
        Participating Companies.

        2.5.    Fund represents that each Portfolio is currently qualified as a
        Regulated Investment Company under Subchapter M of the Code, and that it
        will make every effort to maintain such qualification (under Subchapter
        M or any successor or similar provision) and that it will notify
        Insurance Company immediately upon having a reasonable basis for
        believing that any Portfolio invested in by the Separate Account has
        ceased to so qualify or that it might not so qualify in the future.

        2.6.    Fund agrees that each Portfolio's assets shall be managed and
        invested in a manner that complies with the requirements of Section
        817(h) of the Code.

        2.7.    Insurance Company agrees that the Fund shall be permitted
        (subject to the other terms of this Agreement) to make the Portfolios'
        shares available to other Participating Companies and contractholders
        and to qualified pension and retirement plans.

        2.8.    Fund represents and warrants that any of its directors,
        officers, employees, investment advisers, and other individuals/entities
        who deal with the money and/or securities of the Fund are and shall
        continue to be at all times covered by a blanket fidelity bond or
        similar coverage for the benefit of the Fund in an amount not less than
        that required by Rule 17g-l under the Act. The aforesaid Bond shall
        include coverage for larceny and embezzlement and shall be issued by a
        reputable bonding company.

                                      -2-



        2.9     Insurance Company represents and warrants that all of its
        employees and agents who deal with the money and/or securities of the
        Fund are and shall continue to be at all times covered by a blanket
        fidelity bond or similar coverage in an amount not less than the
        coverage required to be maintained by the Fund. The aforesaid Bond shall
        include coverage for larceny and embezzlement and shall be issued by a
        reputable bonding company.


                                  ARTICLE III.
                                  FUND SHARES

        3.1.    The Contracts funded through the Separate Account will provide
        for the investment of certain amounts in the Portfolios' shares.

        3.2.    Fund agrees to make the shares of its Portfolios available for
        purchase at the then applicable net asset value per share by Insurance
        Company and the Separate Account on each Business Day pursuant to rules
        of the Commission. Notwithstanding the foregoing, the Fund may refuse to
        sell the shares of any Portfolio to any person, or suspend or terminate
        the offering of the shares of any Portfolio if such action is required
        by law or by regulatory authorities having jurisdiction or is, in the
        sole discretion of the Board, acting in good faith and in light of its
        fiduciary duties under federal and any applicable state laws, necessary
        and in the best interests of the shareholders of such Portfolio.

        3.3.    Fund agrees that shares of the Portfolios will be sold only to
        Participating Companies, their separate accounts, the general accounts
        of those Participating Companies and their affiliates and to qualified
        pension and retirement plans. No shares of any Portfolio will be sold to
        the general public.

        3.4.    Fund shall make the net asset value per share of the Portfolios
        available to Insurance Company on a daily basis as soon as reasonably
        practicable after the net asset value per share is calculated but shall
        use its best efforts to make such net asset value available by 6:30 p.m.
        Eastern time. If the Fund provides Insurance Company with materially
        incorrect net asset value per share information through no fault of
        Insurance Company, Insurance Company, on behalf of the Separate Account,
        shall be entitled to an adjustment to the number of shares purchased or
        redeemed to reflect the correct net asset value per share. Any material
        error in the calculation of net asset value per share, dividend or
        capital gain information shall be reported promptly upon discovery to
        Insurance Company.

        3.5.    At the end of each Business Day, Insurance Company will use the
        information described in Section 3.4 to calculate the Separate Account
        unit values for the day. Using this unit value, Insurance Company will
        process the day's Separate Account transactions received by it by the
        close of trading on the floor of the New York Stock Exchange (currently
        4:00 p.m. Eastern time) to determine the net dollar amount of Portfolio
        shares which will be purchased or redeemed at that day's closing net
        asset value per share for such Portfolio. The net purchase or redemption
        orders will be transmitted to the Fund by Insurance Company by [9:00]
        a.m. Eastern time on the Business Day next following Insurance Company's
        receipt of that information. Subject to Sections 3.6 and 3.8, all
        purchase and redemption orders for Insurance Company's General Accounts
        shall be effected at the net asset value per share of the relevant
        Portfolio next calculated after receipt of the order by the Fund or its
        Transfer Agent.

        3.6.    Fund appoints Insurance Company as its agent for the limited
        purpose of accepting orders

                                      -3-



        for the purchase and redemption of shares of each Portfolio for the
        Separate Account. Fund will execute orders for any Portfolio at the
        applicable net asset value per share determined as of the close of
        trading on the day of receipt of such orders by Insurance Company acting
        as agent ("effective trade date"), provided that the Fund receives
        notice of such orders by [9:00] a.m. Eastern time on the next following
        Business Day and, if such orders request the purchase of Portfolio
        shares, the conditions specified in Section 3.8, as applicable, are
        satisfied. A redemption or purchase request for any Portfolio that does
        not satisfy the conditions specified above and in Section 3.8, as
        applicable, will be effected at the net asset value computed for such
        Portfolio on the Business Day immediately preceding the next following
        Business Day upon which such conditions have been satisfied.

        3.7.    Insurance Company will make its best efforts to notify Fund in
        advance of any unusually large purchase or redemption orders.

        3.8.    If Insurance Company's order requests the purchase of Portfolio
        shares, Insurance Company will pay for such purchases by wiring Federal
        Funds to Fund or its designated custodial account on the day the order
        is transmitted. Insurance Company shall make all reasonable efforts to
        transmit to the Fund payment in Federal Funds by [12:00 noon] Eastern
        time on the Business Day the Fund receives the notice of the order
        pursuant to Section 3.5. Fund will execute such orders at the applicable
        net asset value per share determined as of the close of trading on the
        effective trade date if Fund receives payment in Federal Funds by [12:00
        midnight] Eastern time on the Business Day the Fund receives the notice
        of the order pursuant to Section 3.5. If payment in Federal Funds for
        any purchase is not received or is received by the Fund after [12:00
        noon] Eastern time on such Business Day, Insurance Company shall
        promptly upon the Fund's request, reimburse the Fund for any charges,
        costs, fees, interest or other expenses incurred by the Fund in
        connection with any advances to, or borrowings or overdrafts by, the
        Fund, or any similar expenses incurred by the Fund, as a result of
        portfolio transactions effected by the Fund based upon such purchase
        request.

        3.9.    If Insurance Company's order requests a net redemption resulting
        in a payment of redemption proceeds to Insurance Company, the Fund shall
        use its best efforts to wire the redemption proceeds to Insurance
        Company, except as provided below, within three Business Days or, upon
        notice to Insurance Company, such longer period as permitted by the Act
        or the rules, orders or regulations thereunder. If Insurance Company's
        order requests the redemption of Portfolio shares valued at or greater
        than $1 million, the Fund will wire such amount to Insurance Company
        within seven days of the order. If Insurance Company's order requests
        the application of redemption proceeds from the redemption of Portfolio
        shares to the purchase of shares of another Portfolio, the Fund shall so
        apply such proceeds the same Business Day that Insurance Company
        transmits such order to the Fund.

        3.10.   Fund has the obligation to ensure that Portfolio shares are
        registered with the Commission at all times.

        3.11.   Fund will confirm each purchase or redemption order made by
        Insurance Company. Transfer of Portfolio shares will be by book entry
        only. No share certificates will be issued to Insurance Company.
        Insurance Company will record shares ordered from Fund in an appropriate
        title for the corresponding account.

        3.12.   Fund shall credit Insurance Company with the appropriate number
        of shares.

        3.13.   On each ex-dividend date of the Fund or, if not a Business Day,
        on the first Business Day

                                      -4-



        thereafter. Fund shall communicate to Insurance Company the amount of
        dividend and capital gain, if any, per share of each Portfolio. All
        dividends and capital gains of any Portfolio shall be automatically
        reinvested in additional shares of the relevant Portfolio at the
        applicable net asset value per share of such Portfolio on the payable
        date. Fund shall, on the day after the payable date or, if not a
        Business Day, on the first Business Day thereafter, notify Insurance
        Company of the number of shares so issued.

                                  ARTICLE IV.
                             STATEMENTS AND REPORTS

        4.1.    Fund shall provide monthly statements of account as of the end
        of each month for all of Insurance Company's accounts by the fifteenth
        (15th) Business Day of the following month.

        4.2.    At least annually, the Fund or its designee shall provide
        Insurance Company, free of charge, with as many copies of the Fund's
        current Prospectuses as Insurance Company may reasonably request for
        distribution to existing Contractholders and Participants. Fund or its
        designee shall provide Insurance Company, at Insurance Company's
        expense, with as many copies of the Fund's current Prospectuses as
        Insurance Company may reasonably request for distribution to prospective
        purchasers of Contracts. If requested by Insurance Company in lieu
        thereof, the Fund or its designee shall provide such documentation
        (including a "camera ready" copy of the Prospectuses as set in type or,
        at the request of Insurance Company, as a diskette in the form sent to
        the financial printer) and other assistance as is reasonably necessary
        in order for the parties hereto once a year (or more frequently if the
        Prospectuses are supplemented or amended) to have the prospectus for the
        Contracts and the Prospectuses printed together in one document.

        4.3.    Fund shall distribute to Insurance Company copies of the Fund's
        proxy materials, notices, periodic reports and other printed materials
        (which the Fund customarily provides to its shareholders) in quantities
        as Insurance Company may reasonably request for distribution to each
        Contractholder and Participant.

        4.4.    Fund will provide to Insurance Company at least one complete
        copy of all registration statements, Prospectuses, reports, proxy
        statements, sales literature and other promotional materials,
        applications for exemptions, requests for no-action letters, and all
        amendments to any of the above, that relate to the Fund or its shares,
        contemporaneously with the filing of such document with the Commission
        or other regulatory authorities.

        4.5.    Insurance Company will provide to the Fund at least one copy of
        all registration statements, Prospectuses, reports, proxy statements,
        sales literature and other promotional materials, applications for
        exemptions, requests for no-action letters, and all amendments to any of
        the above, that relate to the Contracts or the Separate Account,
        contemporaneously with the filing of such document with the Commission.

                               ARTICLE V. EXPENSES

        5.1.    The charge to the Fund for all expenses and costs of the
        Portfolios, including but not limited to management fees, administrative
        expenses and legal and regulatory costs, will be made in the
        determination of the relevant Portfolio's daily net asset value per
        share.

        5.2.    Except as provided in this Article V and, in particular in the
        next sentence, Insurance

                                      -5-



        Company shall not be required to pay directly any expenses of the Fund
        or expenses relating to the distribution of its shares. Insurance
        Company shall pay the following expenses or costs:

        a.      Such amount of the production expenses of any Fund materials,
                including the cost of printing the Fund's Prospectus, or
                marketing materials for prospective Insurance Company
                Contractholders and Participants as LAM and Insurance Company
                shall agree from time to time.

        b.      Distribution expenses of any Fund materials or marketing
                materials for prospective Insurance Company Contractholders and
                Participants.

        c.      Distribution expenses of Fund materials or marketing materials
                for Insurance Company Contractholders and Participants.

        Except as provided herein and as may be reflected in each Portfolio's
        net asset value per share, all other Fund expenses shall not be borne by
        Insurance Company.

                                   ARTICLE VI.
                                EXEMPTIVE RELIEF

        6.1.    Insurance Company has reviewed a copy of the Order of Exemption
        of the Commission under Section 6(c) of the Act (the "Order") and, in
        particular, has reviewed the conditions to the relief set forth in the
        related Notice. As set forth in the Notice, Insurance Company agrees to
        report any potential or existing conflicts promptly to the Board, and in
        particular whenever contract voting instructions are disregarded, and
        recognizes that it will be responsible for assisting the Board in
        carrying out its responsibilities under such application. Insurance
        Company agrees to carry out such responsibilities with a view to the
        interests of existing Contractholders.

        6.2.    If a majority of the Board, or a majority of Disinterested Board
        Members, determines that a material irreconcilable conflict exists with
        regard to Contractholder investments in the Fund, the Board shall give
        prompt notice to all Participating Companies. If the Board determines
        that Insurance Company is responsible for causing or creating said
        conflict, Insurance Company shall at its sole cost and expense, and to
        the extent reasonably practicable (as determined by a majority of the
        Disinterested Board Members), take such action as is necessary to remedy
        or eliminate the irreconcilable material conflict. Such necessary action
        may include, but shall not be limited to:

        a.      Withdrawing the assets allocable to the Separate Account from
                the Portfolios and reinvesting such assets in a different
                investment medium, or submitting the question of whether such
                segregation should be implemented to a vote or all affected
                Contractholders; and/or

        b.      Establishing a new registered management investment company.

        6.3.    If a material irreconcilable conflict arises as a result of a
        decision by Insurance Company to disregard Contractholder voting
        instructions and said decision represents a minority position or would
        preclude a majority vote by all Contractholders having an interest in
        the Fund, Insurance Company may be required, at the Board's election, to
        withdraw the Separate Account's investment in the Fund.

                                      -6-



        6.4.    For the purpose of this Article, a majority of the Disinterested
        Board Members shall determine whether or not any proposed action
        adequately remedies any irreconcilable material conflict, but in no
        event will the Fund be required to bear the expense of establishing a
        new funding medium for any Contract. Insurance Company shall not be
        required by this Article to establish a new funding medium for any
        Contract if an offer to do so has been declined by vote of a majority of
        the Contractholders materially adversely affected by the irreconcilable
        material conflict.

        6.5.    No action by Insurance Company taken or omitted, and no action
        by the Separate Account or the Fund taken or omitted as a result of any
        act or failure to act by Insurance Company pursuant to this Article VI
        shall relieve Insurance Company of its obligations under, or otherwise
        affect the operation of, Article V.

                                   ARTICLE VII.
                              VOTING OF FUND SHARES

7.1     Insurance Company will provide pass-through voting privileges to all
        Contractholders or Participants as long as the Commission continues to
        interpret the Act as requiring pass-through voting privileges for
        Contractholders or Participants. Accordingly, Insurance Company, where
        applicable, will vote shares of a Portfolio held in its Separate Account
        in a manner consistent with voting instructions timely received from its
        Contractholders or Participants. Insurance Company will be responsible
        for assuring that the Separate Account calculates voting privileges in a
        manner consistent with other Participating Companies. Insurance Company
        will vote shares for which it has not received timely voting
        instructions, as well as shares it owns, in the same proportion as it
        votes those shares for which it has received voting instructions.

7.2     If and to the extent Rule 6e-2 and Rule 6e-3(T) under the Act are
        amended, or if Rule 6e-3 is adopted, to provide exemptive relief from
        any provision of the Act or the rules thereunder with respect to mixed
        and shared funding on terms and conditions materially different from any
        exemptions granted in the Order, then the Fund, and/or the Participating
        Companies, as appropriate, shall take such steps as may be necessary to
        comply with Rule 6e-2 and Rule 6e3(T), as amended, and Rule 6e-3, as
        adopted, to the extent such Rules are applicable.

                                  ARTICLE VIII.
                          MARKETING AND REPRESENTATIONS

        8.1.    The Fund or its underwriter shall periodically furnish Insurance
        Company with the following documents, in quantities as Insurance Company
        may reasonably request:

        a.      Current Prospectus and any supplements thereto;

        b.      other marketing materials.

        Expenses for the production of such documents shall be borne by
        Insurance Company in accordance with Section 5.2 of this Agreement.

        8.2.    Insurance Company shall designate certain persons or entities
        which shall have the requisite licenses to solicit applications for the
        sale of Contracts. No representation is made as to the number or amount
        of Contracts that are to be sold by Insurance Company. Insurance Company
        shall make reasonable efforts to market the Contracts and shall comply
        with all applicable federal and state laws in connection therewith.

                                      -7-



        8.3.    Insurance Company shall furnish, or shall cause to be furnished.
        to the Fund, each piece of sales literature or other promotional
        material in which the Fund, its investment adviser or the administrator
        is named, at least fifteen Business Days prior to its use. No such
        material shall be used unless the Fund approves such material. Such
        approval (if given) must be in writing and shall be presumed not given
        if not received within ten Business Days after receipt of such material.
        The Fund shall use all reasonable efforts to respond within ten days of
        receipt.

        8.4.    Insurance Company shall not give any information or make any
        representations or statements on behalf of the Fund or concerning the
        Fund or any Portfolio in connection with the sale of the Contracts other
        than the information or representations contained in the registration
        statement or Prospectus, as may be amended or supplemented from time to
        time, or in reports or proxy statements for the Fund, or in sales
        literature or other promotional material approved by the Fund.

        8.5.    Fund shall furnish, or shall cause to be furnished, to Insurance
        Company, each piece of the Fund's sales literature or other promotional
        material in which Insurance Company or the Separate Account is named, at
        least fifteen Business Days prior to its use. No such material shall be
        used unless Insurance Company approves such material. Such approval (if
        given) must be in writing and shall be presumed not given if not
        received within ten Business Days after receipt of such material.
        Insurance Company shall use all reasonable efforts to respond within ten
        days of receipt.

        8.6.    Fund shall not, in connection with the sale of Portfolio shares,
        give any information or make any representations on behalf of Insurance
        Company or concerning Insurance Company, the Separate Account, or the
        Contracts other than the information or representations contained in a
        registration statement or prospectus for the Contracts, as may be
        amended or supplemented from time to time, or in published reports for
        the Separate Account which are in the public domain or approved by
        Insurance Company for distribution to Contractholders or Participants,
        or in sales literature or other promotional material approved by
        Insurance Company.

        8.7.    For purposes of this Agreement, the phrase "sales literature or
        other promotional material" or words of similar import include, without
        limitation, advertisements (such as material published, or designed for
        use, in a newspaper, magazine or other periodical, radio, television,
        telephone or tape recording, videotape display, signs or billboards,
        motion pictures or other public media), sales literature (such as any
        written communication distributed or made generally available to
        customers or the public, including brochures, circulars, research
        reports, market letters, form letters, seminar texts, or reprints or
        excerpts of any other advertisement, sales literature, or published
        article), educational or training materials or other communications
        distributed or made generally available to some or all agents or
        employees, registration statements, prospectuses, statements of
        additional information, shareholder reports and proxy materials, and any
        other material constituting sales literature or advertising under
        National Association of Securities Dealers, Inc. rules, the Act or the
        1933 Act.

                                   ARTICLE IX.
                                 INDEMNIFICATION

        9.1.    Insurance Company agrees to indemnify and hold harmless the
        Fund, LAM, any subinvestment adviser of a Portfolio, and their
        affiliates, and each of their directors, trustees, general members,
        officers, employees, agents and each person, if any, who controls or is

                                      -8-



        associated with any of the foregoing entities or persons within the
        meaning of the 1933 Act (collectively" the "Indemnified Parties" for
        purposes of this Section), against any and all losses, claims, damages
        or liabilities joint or several (including any investigative, legal and
        other expenses reasonably incurred in connection with, and any amounts
        paid in settlement of, any action, suit or proceeding or any claim
        asserted) for which the Indemnified Parties may become subject, under
        the 1933 Act or otherwise, insofar as such losses. claims. damages or
        liabilities (or actions in respect to thereof) (i) arise out of or are
        based upon any untrue statement or alleged untrue statement of any
        material fact contained in information furnished by Insurance Company
        for use in the registration statement or Prospectus or sales literature
        or advertisements of the Fund or with respect to the Separate Account or
        Contracts, or arise out of or are based upon the omission or the alleged
        omission to state therein a material fact required to be stated therein
        or necessary to make the statements therein not misleading; (ii) arise
        out of or as a result of conduct, statements or representations (other
        than statements or representations contained in the Prospectus and sales
        literature or advertisements of the Fund) of Insurance Company or its
        agents, with respect to the sale and distribution of Contracts for which
        Portfolio shares are an underlying investment; (iii) arise out of the
        wrongful conduct of Insurance Company or persons under its control with
        respect to the sale or distribution of the Contracts or Portfolio
        shares; (iv) arise out of Insurance Company's incorrect calculation
        and/or untimely reporting of net purchase or redemption orders; or (v)
        arise out of any breach by Insurance Company of a material term of this
        Agreement or as a result of any failure by Insurance Company to provide
        the services and furnish the materials or to make any payments provided
        for in this Agreement. Insurance Company will reimburse any Indemnified
        Party in connection with investigating or defending any such loss,
        claim, damage, liability or action; provided, however, that with respect
        to clauses (i) and (ii) above Insurance Company will not be liable in
        any such case to the extent that any such loss, claim, damage or
        liability arises out of or is based upon any untrue statement or
        omission or alleged omission made in such registration statement,
        prospectus, sales literature, or advertisement in conformity with
        written information furnished to Insurance Company by the Fund
        specifically for use therein. This indemnity agreement will be in
        addition to any liability which Insurance Company may otherwise have.

        9.2.    The Fund agrees to indemnify and hold harmless Insurance Company
        and each of its directors, officers, employees, agents and each person,
        if any, who controls Insurance Company within the meaning of the 1933
        Act against any losses, claims, damages or liabilities to which
        Insurance Company or any such director, officer, employee, agent or
        controlling person may become subject, under the 1933 Act or otherwise,
        insofar as such losses, claims, damages or liabilities (or actions in
        respect thereof) (1) arise out of or are based upon any untrue statement
        or alleged untrue statement of any material fact contained in the
        registration statement or Prospectus or sales literature or
        advertisements of the Fund; (2) arise out of or are based upon the
        omission to state in the registration statement or Prospectus or sales
        literature or advertisements of the Fund any material fact required to
        be stated therein or necessary to make the statements therein not
        misleading; or (3) arise out of or are based upon any untrue statement
        or alleged untrue statement of any material fact contained in the
        registration statement or Prospectus or sales literature or
        advertisements with respect to the Separate Account or the Contracts and
        such statements were based on information provided in writing to
        Insurance Company by the Fund specifically for use therein; and the Fund
        will reimburse any legal or other expenses reasonably incurred by
        Insurance Company or any such director, officer, employee, agent or
        controlling person in connection with investigating or defending any
        such loss, claim, damage, liability or action; provided, however, that
        the Fund will not be liable in any such case to the extent that any such
        loss, claim, damage or liability arises out of or is based upon an
        untrue statement or omission or alleged omission made in such
        Registration Statement, Prospectus, sales literature or advertisements
        in conformity with written information

                                      -9-



        furnished to the Fund by Insurance Company specifically for use therein.
        This indemnity agreement will be in addition to any liability which the
        Fund may otherwise have.

        9.3.    The Fund shall indemnify and hold Insurance Company harmless
        against any and all liability, loss, damages, costs or expenses which
        Insurance Company may incur, suffer or be required to pay due to the
        Fund's (1) incorrect calculation of the daily net asset value, dividend
        rate or capital gain distribution rate of a Portfolio; (2) incorrect
        reporting of the daily net asset value, dividend rate or capital gain
        distribution rate; and (3) untimely reporting of the net asset value,
        dividend rate or capital gain distribution rate; provided that the Fund
        shall have no obligation to indemnify and hold harmless Insurance
        Company if the incorrect calculation or incorrect or untimely reporting
        was the result of incorrect information furnished by Insurance Company
        or information furnished untimely by Insurance Company or otherwise as a
        result of or relating to a breach of this Agreement by Insurance
        Company. In no event will the Fund be liable for any consequential,
        incidental, special or indirect damages resulting to Insurance Company
        hereunder.

        9.4.    Promptly after receipt by an indemnified party under this
        Article of notice of the commencement of any action, such indemnified
        party will, if a claim in respect thereof is to be made against the
        indemnifying party under this Article, notify the indemnifying party of
        the commencement thereof. The omission to so notify the indemnifying
        party will not relieve the indemnifying party from any liability under
        this Article IX, except to the extent that the omission results in a
        failure of actual notice to the indemnifying party and such indemnifying
        party is damaged solely as a result of the failure to give such notice.
        In case any such action is brought against any indemnified party, and it
        notified the indemnifying party of the commencement thereof, the
        indemnifying party will be entitled to participate therein and, to the
        extent that it may wish, assume the defense thereof, with counsel
        satisfactory to such indemnified party, and to the extent that the
        indemnifying party has given notice to such effect to the indemnified
        party and is performing its obligations under this Article, the
        indemnifying party shall not be liable for any legal or other expenses
        subsequently incurred by such indemnified party in connection with the
        defense thereof, other than reasonable costs of investigation.
        Notwithstanding the foregoing, in any such proceeding, any indemnified
        party shall have the right to retain its own counsel, but the fees and
        expenses of such counsel shall be at the expense of such indemnified
        party unless (i) the indemnifying party and the indemnified party shall
        have mutually agreed to the retention of such counsel or (ii) the named
        parties to any such proceeding (including any impleaded parties) include
        both the indemnifying party and the indemnified party and representation
        of both parties by the same counsel would be inappropriate due to actual
        or potential differing interests between them. The indemnifying party
        shall not be liable for any settlement of any proceeding effected
        without its written consent.

        A successor by law of the parties to this Agreement shall be entitled to
        the benefits of the indemnification contained in this Article IX.

                                   ARTICLE X.
                          COMMENCEMENT AND TERMINATION

        10.1.   This Agreement shall be effective as of the date hereof and
        shall continue in force until terminated in accordance with the
        provisions herein.

        10.2.   This Agreement shall terminate without penalty as to one or more
        Portfolios at the option

                                      -10-



        of the terminating party:

        a.      At the option of Insurance Company or the Fund at any time from
                the date hereof upon 180 days' notice, unless a shorter time is
                agreed to by the parties;

        b.      At the option of Insurance Company, if shares of any Portfolio
                are not reasonably available to meet the requirements of the
                Contracts as determined by Insurance Company. Prompt notice of
                election to terminate shall be furnished by Insurance Company,
                said termination to be effective ten days after receipt of
                notice unless the Fund makes available a sufficient number of
                shares to meet the requirements of the Contracts within said
                ten-day period;

        c.      At the option of Insurance Company, upon the institution of
                formal proceedings against the Fund by the Commission, the
                National Association of Securities Dealers, Inc. or any other
                regulatory body, the expected or anticipated ruling, judgment or
                outcome of which would, in Insurance Company's reasonable
                judgment, materially impair the Fund's ability to meet and
                perform the Fund's obligations and duties hereunder. Prompt
                notice of election to terminate shall be furnished by Insurance
                Company with said termination to be effective upon receipt of
                notice;

        d.      At the option of the Fund, upon the institution of formal
                proceedings against Insurance Company by the Commission, the
                National Association of Securities Dealers, Inc. or any other
                regulatory body, the expected or anticipated ruling, judgment or
                outcome of which would, in the Fund's reasonable judgment,
                materially impair Insurance Company's ability to meet and
                perform Insurance Company's obligations and duties hereunder.
                Prompt notice of election to terminate shall be furnished by the
                Fund with said termination to be effective upon receipt of
                notice;

        e.      At the option of the Fund, if the Fund shall determine, in its
                sole judgment reasonably exercised in good faith, that Insurance
                Company has suffered a material adverse change in its business
                or financial condition or is the subject of material adverse
                publicity and such material adverse change or material adverse
                publicity is likely to have a material adverse impact upon the
                business and operation of the Fund or LAM, the Fund shall notify
                Insurance Company in writing of such determination and its
                intent to terminate this Agreement, and after considering the
                actions taken by Insurance Company and any other changes in
                circumstances since the giving of such notice, such
                determination of the Fund shall continue to apply on the
                sixtieth (60th) day following the giving of such notice, which
                sixtieth day shall be the effective date of termination;

        f.      Upon termination of the Investment Management Agreement between
                the Fund and LAM or its successors unless Insurance Company
                specifically approves the selection of a new Fund investment
                adviser. The Fund shall promptly furnish notice of such
                termination to Insurance Company;

        g.      In the event Portfolio shares are not registered, issued or sold
                in accordance with applicable federal law, or such law precludes
                the use of such shares as the underlying investment medium of
                Contracts issued or to be issued by Insurance Company.
                Termination shall be effective immediately upon such occurrence
                without notice;

        h.      At the option of the Fund upon a determination by the Board in
                good faith that it is no longer advisable and in the best
                interests of shareholders for the Fund to continue to

                                      -11-



                operate pursuant to this Agreement. Termination pursuant to this
                Subsection (h) shall be effective upon notice by the Fund to
                Insurance Company of such termination;

        i.      At the option of the Fund if the Contracts cease to qualify as
                annuity contracts or life insurance policies. as applicable,
                under the Code, or if the Fund reasonably believes that the
                Contracts may fail to so qualify;

        j.      At the option of Insurance Company or the Fund, upon a party's
                breach of any material provision of this Agreement, which breach
                has not been cured to the satisfaction of the non-breaching
                party within 10 days after written notice of such breach is
                delivered to the breaching party;

        k.      At the option of the Fund, if the Contracts are not registered,
                issued or sold in accordance with applicable federal and/or
                state law; or

        l.      Upon assignment of this Agreement, unless made with the written
                consent of the non-assigning party.

        Any such termination pursuant to this Article X shall not affect the
        operation of Article V of this Agreement. Any termination of this
        Agreement shall not affect the operation of Article IX of this
        Agreement.

        10.3.   Notwithstanding any termination of this Agreement pursuant to
        Section 10.2 hereof, the Fund and LAM may, at the option of the Fund,
        continue to make available additional Portfolio shares for so long as
        the Fund desires pursuant to the terms and conditions of this Agreement
        as provided below, for all Contracts in effect on the effective date of
        termination of this Agreement (hereinafter referred to as "Existing
        Contracts"). Specifically, without limitation, if the Fund or LAM so
        elects to make additional Portfolio shares available, the owners of the
        Existing Contracts or Insurance Company, whichever shall have legal
        authority to do so, shall be permitted to reallocate investments in the
        Portfolio, redeem investments in the Fund and/or invest in the Fund upon
        the making of additional purchase payments under the Existing Contracts.
        In the event of a termination of this Agreement pursuant to Section 10.2
        hereof, the Fund and LAM, as promptly as is practicable under the
        circumstances, shall notify Insurance Company whether LAM and the Fund
        will continue to make Portfolio shares available after such termination.
        If Portfolio shares continue to be made available after such
        termination, the provisions of this Agreement shall remain in effect and
        thereafter either the Fund or Insurance Company may terminate the
        Agreement, as so continued pursuant to this Section 10.3, upon prior
        written notice to the other party, such notice to be for a period that
        is reasonable under the circumstances but, if given by the Fund, need
        not be for more than six months.

                                   ARTICLE XI.
                                   AMENDMENTS

        11.1.   Any changes in the terms of this Agreement shall be made by
        agreement in writing by the parties hereto.

                                      -12-



                                  ARTICLE XII.
                                     NOTICE

        12.1.   Each notice required by this Agreement shall be given by
        certified mail, return receipt requested, to the appropriate parties at
        the following addresses:

        Insurance Company: Conseco Variable Insurance Company
                           11815 North Pennsylvania
                           Carmel, IN 46032
                           Attention: L. Gregory Gloeckner

        Fund:              Lazard Retirement Series, Inc.
                           30 Rockefeller Plaza
                           New York, New York 10020
                           Attention: William Butterly

        LAM:               Lazard Asset Management
                           30 Rockefeller Plaza
                           New York, New York 10020
                           Attention: Steven Swain

        with copies to:    Stroock & Stroock & Lavan LLP
                           180 Maiden Lane
                           New York, New York 10038-4982
                           Attn: Stuart H. Coleman, Esq.

        Notice shall be deemed to be given on the date of receipt by the
        addresses as evidenced by the return receipt.

                                  ARTICLE XIII.
                                  MISCELLANEOUS

        13.1.   This Agreement has been executed on behalf of the Fund by the
        undersigned officer of the Fund in his capacity as an officer of the
        Fund.

                                  ARTICLE XIV.
                                       LAW

        14.1.   This Agreement shall be construed in accordance with the
        internal laws of the State of New York, without giving effect to
        principles of conflict of laws.

                                      -13-



IN WITNESS WHEREOF, the parties hereto have executed this Agreement to be duly
executed and attested as of the date first above written.

                                        CONSECO VARIABLE INSURANCE
                                        COMPANY

                                        By: /s/
                                            -----------------------------


Attest:
          -----------------------------


                                        LAZARD RETIREMENT SERIES, INC.



                                        By: /s/ ROBERT P. MORGANTHAU
                                            -----------------------------
                                                Robert P. Morganthau
                                                Managing Director

Attest:   /S/
          -----------------------------


                                        LAZARD ASSET MANAGEMENT,
                                        a division of Lazard Freres & Co., LLC

                                        By: /s/ ROBERT P. MORGANTHAU
                                            -----------------------------
                                                Robert P. Morganthau
                                                Managing Director

Attest:
          -----------------------------




                                      -14-



                                   SCHEDULE 1


NAME OF PORTFOLIO

Lazard Retirement Equity Portfolio
Lazard Retirement Small Cap Portfolio